Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells

被引:1
|
作者
Faircloth, Tyler U. [1 ]
Temple, Sara [1 ]
Parr, Rhett N. [1 ]
Tucker, Anna B. [1 ]
Rajan, Devi [1 ]
Hematti, Peiman [2 ]
Kugathasan, Subra [3 ,4 ]
Chinnadurai, Raghavan [1 ]
机构
[1] Mercer Univ, Sch Med, Dept Biomed Sci, 250 E 66th St, Macon, GA 31404 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[3] Emory Univ, Sch Med, Div Pediat Gastroenterol, Dept Pediat, Atlanta, GA USA
[4] Childrens Healthcare Atlanta, Atlanta, GA USA
关键词
mesenchymal stromal/stem cells; secretome; angiogenic factors; immunosuppression; human large intestinal endothelial cells; vascular endothelial growth factor A; INFLAMMATORY-BOWEL-DISEASE; OXIDE SYNTHASE INHIBITOR; NITRIC-OXIDE; STEM-CELLS; CROHNS-DISEASE; INTERNATIONAL SOCIETY; ANGIOGENIC PROPERTIES; PERIANAL FISTULAS; INTERFERON-GAMMA; L-NMMA;
D O I
10.1093/stmcls/sxae040
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stromal cells (MSCs) are investigated as cellular therapeutics for inflammatory bowel diseases and associated perianal fistula, although consistent efficacy remains a concern. Determining host factors that modulate MSCs' potency including their secretion of angiogenic and wound-healing factors, immunosuppression, and anti-inflammatory properties are important determinants of their functionality. We investigated the mechanisms that regulate the secretion of angiogenic and wound-healing factors and immune suppression of human bone marrow MSCs. Secretory analysis of MSCs focusing on 18 angiogenic and wound-healing secretory molecules identified the most abundancy of vascular endothelial growth factor A (VEGF-A). MSC viability and secretion of other angiogenic factors are not dependent on VEGF-A secretion which exclude the autocrine role of VEGF-A on MSC's fitness. However, the combination of inflammatory cytokines IFN gamma and TNF alpha reduces MSC's VEGF-A secretion. To identify the effect of intestinal microvasculature on MSCs' potency, coculture analysis was performed between human large intestine microvascular endothelial cells (HLMVECs) and human bone marrow-derived MSCs. HLMVECs do not attenuate MSCs' viability despite blocking their VEGF-A secretion. In addition, HLMVECs neither attenuate MSC's IFN gamma mediated upregulation of immunosuppressive enzyme indoleamine 2,3-dioxygenase nor abrogate suppression of T-cell proliferation despite the attenuation of VEGF-A secretion. We found that HLMVECs express copious amounts of endothelial nitric oxide synthase and mechanistic analysis showed that pharmacological blocking reverses HLMVEC-mediated attenuation of MSC's VEGF-A secretion. Together these results suggest that secretion of VEGF-A and immunosuppression are separable functions of MSCs which are regulated by distinct mechanisms in the host. Graphical Abstract
引用
收藏
页码:736 / 751
页数:16
相关论文
共 50 条
  • [21] Human Primary Bone Marrow Mesenchymal Stromal Cells and Their in vitro Progenies Display Distinct Transcriptional Profile Signatures
    Ghazanfari, Roshanak
    Zacharaki, Dimitra
    Li, Hongzhe
    Lim, Hooi Ching
    Soneji, Shamit
    Scheding, Stefan
    SCIENTIFIC REPORTS, 2017, 7
  • [22] Ibuprofen in Therapeutic Concentrations Affects the Secretion of Human Bone Marrow Mesenchymal Stromal Cells, but Not Their Proliferative and Migratory Capacity
    Kulesza, Agnieszka
    Zielniok, Katarzyna
    Hawryluk, Jakub
    Paczek, Leszek
    Burdzinska, Anna
    BIOMOLECULES, 2022, 12 (02)
  • [23] Mesenchymal Stromal Cells Mitigate Experimental Colitis via Insulin-like Growth Factor Binding Protein 7-mediated Immunosuppression
    Liao, Yan
    Lei, Junxia
    Liu, Muyun
    Lin, Wanwen
    Hong, Dongxi
    Tuo, Ying
    Jiang, Mei Hua
    Xia, Huimin
    Wang, Maosheng
    Huang, Weijun
    Xiang, Andy Peng
    MOLECULAR THERAPY, 2016, 24 (10) : 1860 - 1872
  • [24] Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain
    Pischiutta, Francesca
    D'Amico, Giovanna
    Dander, Erica
    Biondi, Andrea
    Biagi, Ettore
    Citerio, Giuseppe
    De Simoni, Maria Grazia
    Zanier, Elisa R.
    NEUROPHARMACOLOGY, 2014, 79 : 119 - 126
  • [25] Heparin Anticoagulant for Human Bone Marrow Does Not Influence In Vitro Performance of Human Mesenchymal Stromal Cells
    Roger, Yvonne
    Burmeister, Laura
    Hamm, Anika
    Elger, Kirsten
    Dittrich-Breiholz, Oliver
    Florkemeier, Thilo
    Hoffmann, Andrea
    CELLS, 2020, 9 (07)
  • [26] Assessment of DNA Damage in Human Bone Marrow Cells and Multipotent Mesenchymal Stromal Cells
    Nikitina, V. A.
    Chausheva, A. I.
    Zhanataev, A. K.
    Osipova, E. Yu.
    Durnev, A. D.
    Bochkov, N. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 151 (04) : 550 - 552
  • [27] Vasculogenic Potency of Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells Results in Differing Vascular Network Phenotypes in a Microfluidic Chip
    Mykuliak, Anastasiia
    Yrjanainen, Alma
    Maki, Antti-Juhana
    Gebraad, Arjen
    Lampela, Ella
    Kaariainen, Minna
    Pakarinen, Toni-Karri
    Kallio, Pasi
    Miettinen, Susanna
    Vuorenpaa, Hanna
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [28] Assessment of DNA Damage in Human Bone Marrow Cells and Multipotent Mesenchymal Stromal Cells
    V. A. Nikitina
    A. I. Chausheva
    A. K. Zhanataev
    E. Yu. Osipova
    A. D. Durnev
    N. P. Bochkov
    Bulletin of Experimental Biology and Medicine, 2011, 151 : 550 - 552
  • [29] Activated T cells modulate immunosuppression by embryonic- and bone marrow-derived mesenchymal stromal cells through a feedback mechanism
    Lin, Wenyu
    Oh, Steve K. W.
    Choo, Andre B. H.
    George, Andrew J. T.
    CYTOTHERAPY, 2012, 14 (03) : 274 - 284
  • [30] Proliferative Potential of Multipotent Mesenchymal Stromal Cells from Human Bone Marrow
    Zhironkina, O. A.
    Shipounova, I. N.
    Bigildeev, A. E.
    Sats, N. V.
    Petinati, N. A.
    Drize, N. I.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 152 (04) : 543 - 547